Life Sciences Deals Unlocking: LifeArc Ventures Sees Pace Of Investments Pick Up
UK Investor’s Follow-On And New Fundings Point To More Promising Investment Climate
Attrition among biotechs and VCs holding onto their reserve capital for existing investments may have reduced the capital available for new life sciences funding, but UK-based LifeArc Ventures believes its recent activity is indicative of a general upswing.
